Sanofi Wants Claims Against Mylan Out Of EpiPen MDL
Sanofi-Aventis US LLC urged a Kansas federal court on Thursday to recommend its suit accusing EpiPen maker Mylan Inc. of using anti-competitive practices to hurt sales of its competing emergency allergy...To view the full article, register now.
Already a subscriber? Click here to view full article